James T Corcoran

September 29, 2022 | New Jersey Law Journal

The primary goal of a patent practitioner performing due diligence of a new drug should be to identify all risks associated with commercialization of the drug product and to determine the potential for market exclusivity.

By James T. Corcoran

8 minute read

September 12, 2019 | New Jersey Law Journal

Patent practitioners, especially those in the pharmaceutical industry, should be mindful of taking any action that might result in applicant delay, especially in the context of supplemental replies and information disclosure statements.

By James T. Corcoran

8 minute read